# PLERIXAFOR
> **ANDA211901** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2023-07-24
## Drug
- **FDA Application Number:** ANDA211901
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PLERIXAFOR
- **Generic name:** PLERIXAFOR
- **Active ingredients:** PLERIXAFOR
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **Manufacturer:** Novadoz Pharmaceuticals LLC
- **First approval:** 2023-07-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211901)
---
*AI Analytics · CC0 1.0*